Metabolomics of Hydrazine-Induced Hepatotoxicity in Rats for Discovering Potential Biomarkers

Metabolic pathway disturbances associated with drug-induced liver injury remain unsatisfactorily characterized. Diagnostic biomarkers for hepatotoxicity have been used to minimize drug-induced liver injury and to increase the clinical safety. A metabolomics strategy using rapid-resolution liquid chromatography/tandem mass spectrometry (RRLC-MS/MS) analyses and multivariate statistics was implemented to identify potential biomarkers for hydrazine-induced hepatotoxicity. The global serum and urine metabolomics of 30 hydrazine-treated rats at 24 or 48 h postdosing and 24 healthy rats were characterized by a metabolomics approach. Multivariate statistical data analyses and receiver operating characteristic (ROC) curves were performed to identify the most significantly altered metabolites. The 16 most significant potential biomarkers were identified to be closely related to hydrazine-induced liver injury. The combination of these biomarkers had an area under the curve (AUC) > 0.85, with 100% specificity and sensitivity, respectively. This high-quality classification group included amino acids and their derivatives, glutathione metabolites, vitamins, fatty acids, intermediates of pyrimidine metabolism, and lipids. Additionally, metabolomics pathway analyses confirmed that phenylalanine, tyrosine, and tryptophan biosynthesis as well as tyrosine metabolism had great interactions with hydrazine-induced liver injury in rats. These discriminating metabolites might be useful in understanding the pathogenesis mechanisms of liver injury and provide good prospects for drug-induced liver injury diagnosis clinically.

• Publication year

  2018

• Venue

  Disease Markers

• Publication date

  2018-04-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1155/2018/8473161PMID 29849827PMCID 5914126
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum markers for mitochondrial dysfunction and cell death are possible predictive indicators for drug‐induced liver injury by direct acting antivirals

  2018cited by this paper
• Plasma Amino Acid Profile in Patients with Aortic Dissection

  2017cited by this paper
• Metabonomics Research Progress on Liver Diseases

  2017cited by this paper
• Metabolic Phenotype of Obesity in a Saudi Population.

  2017cited by this paper
• NMR-based metabolomic approach to study urine samples of chronic inflammatory rheumatic disease patients

  2017cited by this paper
• Drug-induced liver injury due to antibiotics

  2017cited by this paper
• Drug-Induced Acute Liver Injury Within 12 Hours After Fluvastatin Therapy.

  2016cited by this paper
• Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects.

  2016cited by this paper
• Metabolic Disturbances in Adult-Onset Still’s Disease Evaluated Using Liquid Chromatography/Mass Spectrometry-Based Metabolomic Analysis

  2016cited by this paper
• Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system.

  2015cited by this paper
• Metabonomic analysis of the joint toxic action of long-term low-level exposure to a mixture of four organophosphate pesticides in rat plasma.

  2014cited by this paper
• Metabolomics Coupled with Pattern Recognition and Pathway Analysis on Potential Biomarkers in Liver Injury and Hepatoprotective Effects of Yinchenhao

  2014cited by this paper
• Toxic effects of chronic low-dose exposure of thioacetamide on rats based on NMR metabolic profiling.

  2014cited by this paper
• Metabonomics evaluation of urine from rats administered with phorate under long‐term and low‐level exposure by ultra‐performance liquid chromatography‐mass spectrometry

  2014cited by this paper
• Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review

  2014cited by this paper
• Toward predictive models for drug-induced liver injury in humans: are we there yet?

  2014cited by this paper
• Niacin induced coagulopathy as a manifestation of occult liver injury.

  2013cited by this paper
• A mathematical model of tryptophan metabolism via the kynurenine pathway provides insights into the effects of vitamin B-6 deficiency, tryptophan loading, and induction of tryptophan 2,3-dioxygenase on tryptophan metabolites.

  2013cited by this paper
• Assessing moderate to vigorous physical activity in rural West Virginia elementary school physical education classes.

  2013cited by this paper
• B-Vitamin dependent methionine metabolism and alcoholic liver disease

  2013cited by this paper
• Assessment of data pre-processing methods for LC-MS/MS-based metabolomics of uterine cervix cancer.

  2013cited by this paper
• I and J

  2012cited by this paper
• Metabolomics analysis for biomarker discovery: advances and challenges.

  2012cited by this paper
• Assessment of nonsteroidal anti-inflammatory drug-induced hepatotoxicity

  2011cited by this paper
• [Carnitine: function, metabolism and value in hepatic failure during chronic alcohol intoxication].

  2011cited by this paper
• GC‐MS‐based metabolomics reveals mechanism of action for hydrazine induced hepatotoxicity in rats

  2011cited by this paper
• HPLC-MS/MS methods for the quantitative analysis of 5-oxoproline (pyroglutamate) in rat plasma and hepatic cell line culture medium.

  2011cited by this paper
• Antibiotic-induced liver toxicity: mechanisms, clinical features and causality assessment.

  2010cited by this paper
• The Characteristics and Clinical Outcome of Drug-induced Liver Injury: A Single-center Experience

  2010cited by this paper
• Hepatotoxic effects of therapies for tuberculosis

  2010cited by this paper
• Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer.

  2010cited by this paper
• Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

  2009cited by this paper
• RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer.

  2009cited by this paper
• Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research

  2009cited by this paper
• Metabonomics evaluation of urine from rats given acute and chronic doses of acetaminophen using NMR and UPLC/MS.

  2008cited by this paper
• Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models.

  2008cited by this paper
• Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

  2008cited by this paper
• Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine.

  2007cited by this paper
• Influence of cultivation temperature on the ligninolytic activity of selected fungal strains

  2006cited by this paper
• Protective role of carnitine ester against radiation-induced oxidative stress in rats.

  2006cited by this paper
• Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies.

  2006cited by this paper
• Multi- and Megavariate Data Analysis : Part II: Advanced Applications and Method Extensions

  2006cited by this paper
• HPLC-MS-based methods for the study of metabonomics.

  2005cited by this paper
• Comparative metabonomics of differential hydrazine toxicity in the rat and mouse.

  2005cited by this paper
• Integrated metabonomic analysis of the multiorgan effects of hydrazine toxicity in the rat.

  2005cited by this paper
• Processing methods for differential analysis of LC/MS profile data

  2005cited by this paper
• Combination of ‘omics’ data to investigate the mechanism(s) of hydrazine-induced hepatotoxicity in Rats and to identify potential biomarkers

  2004cited by this paper
• Understanding 'Global' Systems Biology: Metabonomics and the Continuum of Metabolism

  2003cited by this paper
• Metabonomic investigations into hydrazine toxicity in the rat.

  2001cited by this paper
• I and i

  2001cited by this paper
• Slow-binding inhibition of gamma-aminobutyric acid aminotransferase by hydrazine analogues.

  1996cited by this paper
• Slow-Binding Inhibition of γ-Aminobutyric Acid Aminotransferase by Hydrazine Analogues†,‡

  1996cited by this paper
• Measuring the accuracy of diagnostic systems.

  1988cited by this paper
• Plasma levels of pipecolic acid in patients with chronic liver disease

  1988cited by this paper
• Effect of "drugs for liver disease" on hepatotoxic action of carbon tetrachloride. II. Effect of protoporphyrin and phosphorylcholine on microsomal drug-metabolizing enzyme activities and the components in injuried liver.

  1975cited by this paper
• [Indolepatterns in the urine of liver patients].

  1962cited by this paper
• Indolmuster im Urin Leberkranker

  1962cited by this paper

• Pluchea dioscoridis extract: A novel therapeutic approach for polycystic ovary syndrome targeting ovarian morphology, dopamine pathways, and neurobehavior in relation to its phytocomponents

  2025cites this paper
• Neuroprotective potential of Erigeron bonariensis ethanolic extract against ovariectomized/D-galactose-induced memory impairments in female rats in relation to its metabolite fingerprint as revealed using UPLC/MS

  2024cites this paper
• Uncovering the protective mechanism of Pien-Tze-Huang in rat with alcoholic liver injury based on cytokines analysis and untargeted metabonomics.

  2023cites this paper
• Untargeted serum and liver metabolomics analyses reveal the gastroprotective effect of polysaccharide from Evodiae fructus on ethanol-induced gastric ulcer in mice.

  2023cites this paper
• Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury

  2022cites this paper
• Functional Characterization of the Effects of N-acetyltransferase 2 Alleles on N-acetylation of Eight Drugs and Worldwide Distribution of Substrate-Specific Diversity

  2021cites this paper
• UPLC-Q-TOF/MS-Based Metabolomics Approach to Reveal the Hepatotoxicity of Emodin and Detoxification of Dihydromyricetin

  2021cites this paper
• Role of Hydrazine-Related Chemicals in Cancer and Neurodegenerative Disease.

  2021cites this paper
• Toxicometabolomics: Small Molecules to Answer Big Toxicological Questions

  2021cites this paper
• Safety assessment of cosmetics by read across applied to metabolomics data of in vitro skin and liver models

  2021cites this paper
• Gas explosion-induced acute blast lung injury assessment and biomarker identification by a LC-MS-based serum metabolomics analysis

  2020influential citation
• Targeted amino acid and related amines analysis based on iTRAQ®-LC-MS/MS for discovering potential hepatotoxicity biomarkers.

  2020cites this paper
• Elucidation of the Molecular Mechanisms Underlying Sorafenib-Induced Hepatotoxicity

  2020cites this paper
• UPLC/MS/MS-Based Metabolomics Study of the Hepatotoxicity and Nephrotoxicity in Rats Induced by Polygonum multiflorum Thunb.

  2020cites this paper
• Study on the mechanism of cantharidin-induced hepatotoxicity in rat using serum and liver metabolomics combined with conventional pathology methods.

  2020cites this paper
• LC-MS-Based Metabolomic Study of Oleanolic Acid-Induced Hepatotoxicity in Mice

  2020cites this paper
• Serum metabolomics analysis of mice that received repeated airway exposure to a water-soluble PM2.5 extract.

  2019cites this paper